Fibromyalgia syndrome: Prevalence, pharmacological and non-pharmacological interventions in outpatient health care. An analysis of statutory health insurance data

Joint Bone Spine

Volumn 78, Issue 1, 2011, Pages 80-84

  Sauer, Kristin ^a   Kemper, Claudia ^a   Glaeske, Gerd ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

Chronic widespread pain; Epidemiology; Fybromyalgia; Health insurance data; Health service research

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PRAMIPEXOL; PRAMIPEXOLE; PREGABALIN; TRAMADOL; TROPISETRON; UNCLASSIFIED DRUG;

ARTICLE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; FIBROMYALGIA; HEALTH INSURANCE; HUMAN; OUTPATIENT CARE; PHYSIOTHERAPY; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; COGNITIVE THERAPY; COMORBIDITY; FEMALE; FIBROMYALGIA; GERMANY; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; OUTPATIENTS; PHYSICAL THERAPY MODALITIES; PREVALENCE; YOUNG ADULT;

EID: 78651069928     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.05.003     Document Type: Article

References (27)

1. Widder B., Hausotter W., Husstedt I.W., et al. Sichtbarmachung einer Fiktion-die neue S3-Leitlinie [letter to the editor about the new guideline on the diagnosis and treatment of the fibromyalgia syndrome]. der Schmerz 2009, 23:72-76. [Article in German].
2. Goldenberg D.L Fibromyalgia syndrome a decade later - what have we learned?. Arch Intern Med 1999, 159:777-785.
3. Assumpção A., Cavalcante A.B., Capela C.E. Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord 2009, 10:1471-2474.
4. Bannwarth B., Blotman F., Roué-Le Lay K., et al. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 2008, 78:184-187.
5. Diemer W., Burchert H. GBE Heft 7 [Chronic pain]. Chronische Schmerzen 2002, 7:13-18. [Article in German].
6. Gustorff B., Dorner T., Likar R., et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol Scand 2008, 52(1):132-136.
7. Gormsen L., Rosenberg R., Bach F., et al. Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain 2010, 14:127.
8. Bellach B.M., Ellert U., Radoschewski M. Epidemiologie des Schmerzes-Ergebnisse des Bundesgesundheitssurvey 1998 [epidemiology of pain-results from the German National Health Survey 1998]. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2000, 43:421-431. [Article in German].
9. Neumann L., Berzak A., Buskila D. Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 2000, 29:400-408.
10. Hoffman D.L., Dukes E.M. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 2008, 62:115-126.
11. Kivimäki M., Leino-Arjas P., Kaila-Kangas L., et al. Increased absence due to sickness among employees with fibromyalgia. Ann Rheum Dis 2007, 66:65-69.
12. Boonen A., van den Heuvel R., van Tubergen A., et al. Large differences in cost of illness and well-being between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 2005, 64:396-402.
13. Silverman S., Dukes E.M., Johnston S.S., et al. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin 2009, 25:829-840.
14. Robinson R., Birnbaum H., Morley M., et al. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. J Rheumatol 2004, 31:1621-1629.
15. Diemer W., Burchert H. Health report Germany (Gesundheitsberichterstattung des Bundes). Chronische Schmerzen - GBE-Heft 2002, 7:5-18. Robert Koch Institut (RKI).
16. Sarzi-Puttini P., Buskila D., Carrabba M., et al. Treatment strategy in fibromyalgia syndrome: where are we now?. Semin Arthritis Rheum 2008, 37:353-365.
17. Carville S.F., Arendt-Nielsen S., Bliddal H., et al. EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008, 67:536-541.
18. Häuser W., Bernardy K., Arnold B., et al. The efficacy of multicomponent treatment in fibromyalgia syndome: a meta-analyses of randomized controlled trials. Arthritis Rheum 2009, 61:216-224.
19. Karmisholt K., Gøtzsche P.C. Physical activity for secondary prevention of disease. Systematic reviews if randomized clinical trials. Dan Med Bull 2005, 52:90-94.
20. Jones K.D., Adams D., Winters Stone K., et al. A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988 to 2005). Health Qual Life Outcomes 2006, 4:67.
21. Rooks S.D., Gautam S., Romeling M., et al. Group exercise, education, and combination of self-management on woman with fibromyalgia. Arch Intern Med 2007, 167:2192-2199.
22. Beyer L. Fibromylagie [Fibromyalgia]. Manuelle Medizin 2008, 46:285-290. [Article in German].
23. Kayser H., Thoma R., Mertens E., et al. Struktur der ambulanten Schmerztherapie in Deutschland [Structure of outpatient health care for pain in Germany]. Der Schmerz 2008, 22:424-432. [Article in German].
24. Statistisches Bundesamt Deutschland (StaBu). Tabellen zum Bevölkerungsstand nach Alter und Geschlecht [statistics of the German population, site in German cited 2009 Okt 03]. 2009.
25. Bramesfeld A., Grobe T., Schwartz F.W. Prevelance of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data. Soc Psychiatry Psychiat Epidemiol 2010, 45:329-335.
26. Bramesfeld A., Grobe T., Schwartz F.W. Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany. Soc Psychiatry Psychiatr Epidemiol 2007, 42:740-746.
27. Glaeske G, Schicktanz C, Janhsen K. GEK-Arzneimittelreport 2008. Auswertungsergebnisse der GEK-Arzneimitteldaten aus den Jahren 2006 bis 2007. St. Augustin: Asgard-Verlag; 2008.